Summit Therapeutics to explore further clinical development of ivonescimab
PremiumThe FlySummit Therapeutics to explore further clinical development of ivonescimab
4d ago
Summit Therapeutics price target raised to $45 from $30 at H.C. Wainwright
Premium
The Fly
Summit Therapeutics price target raised to $45 from $30 at H.C. Wainwright
4d ago
Instil Bio surges after Baird target calls for shares tripling
Premium
The Fly
Instil Bio surges after Baird target calls for shares tripling
7d ago
Instil Bio price target raised to $40 from $25 at H.C. Wainwright
PremiumThe FlyInstil Bio price target raised to $40 from $25 at H.C. Wainwright
8d ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
9d ago
Summit Stock Soars 56%: Stifel Predicts Even More Upside Ahead
Premium
Market News
Summit Stock Soars 56%: Stifel Predicts Even More Upside Ahead
10d ago
Summit Therapeutics price target raised to $19 from $13 at Citi
PremiumThe FlySummit Therapeutics price target raised to $19 from $13 at Citi
11d ago
Summit Therapeutics price target raised to $30 from $16 at H.C. Wainwright
Premium
The Fly
Summit Therapeutics price target raised to $30 from $16 at H.C. Wainwright
11d ago
Summit soars after lung cancer drug shows benefits versus Keytruda
Premium
The Fly
Summit soars after lung cancer drug shows benefits versus Keytruda
11d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100